Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration

Su-Hyeong Kim1, Anuradha Sehrawat, Shivendra V Singh

  • 1Department of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 2.32A Hillman Cancer Center Research Pavilion, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.

Insights

Benzyl isothiocyanate (BITC) activates Notch2 signaling in breast cancer cells, hindering its own migration-inhibiting effects. This finding clarifies BITC

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Benzyl isothiocyanate (BITC) shows anticancer potential against breast cancer.
  • The precise mechanisms of BITC's anticancer effects, particularly involving Notch signaling, remain unclear.
  • Notch signaling is frequently dysregulated in human breast cancer.

Purpose of the Study:

  • To investigate the role of Notch signaling in the anticancer responses to BITC.
  • To determine how BITC affects Notch pathway activation in breast cancer cells.
  • To elucidate the specific Notch receptors involved in BITC's effects on cell migration and viability.

Main Methods:

  • Treatment of human breast cancer cell lines (MCF-7, MDA-MB-231, SUM159) with BITC.
  • Assessment of Notch receptor cleavage and activation using Western blotting and luciferase reporter assays.
  • Inhibition of Notch signaling via γ-secretase inhibitors and RNA interference (siRNA, shRNA).
  • In vivo studies using MDA-MB-231 xenografts in rodents.

Main Results:

  • BITC induced cleavage and activation of Notch1, Notch2, and Notch4 in breast cancer cells.
  • BITC-mediated inhibition of cell migration was enhanced by Notch2 knockdown, but not Notch1 or Notch4.
  • BITC treatment increased cleaved Notch2 and Hes-1 protein levels in xenograft tumors.
  • Notch2 activation was found to impede the inhibitory effect of BITC on cell migration.

Conclusions:

  • BITC activates Notch2 signaling in both cultured and xenografted human breast cancer cells.
  • Notch2 activation by BITC counteracts BITC's inhibitory effects on cancer cell migration.
  • Understanding this interaction is crucial for developing effective BITC-based cancer therapies.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...